Novo Nordisk A/S
Novo Nordisk A/S (NOVO-B.CO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NOVO-B.CO · as of Jun 9, 2026
Key Statistics
Explore Novo Nordisk A/S Data
novo-b.co stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 25 · Buy rate: 72.0%
Competitors & Peers
novo-b.co competitorsNOVO-B.CO
ALK-B.CO
BAVA.CO
DEMANT.CO
GMAB.CO
GN.COStock Performance
Full HistoryAbout Novo Nordisk A/S
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided …
what is novo nordisk a/s · novo-b.co stock overview · novo nordisk a/s company profile · who is novo nordisk a/s ceo · novo-b.co CPH · novo nordisk a/s headquarters · novo nordisk a/s business segments
About Stock Overview & Key Data
Novo Nordisk A/S (NOVO-B.CO) is a Healthcare company in the Biotechnology industry, listed on CPH since Jan 6, 2001. As of the latest trading session, NOVO-B.CO stock price is $266.55, with a market capitalization of $1.18T. The stock has returned -48.72% over the past 12 months and -19.29% year-to-date.
According to 25 Wall Street analysts, the consensus rating for Novo Nordisk A/S stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Novo Nordisk A/S reported revenue of $309.1B and net income of $102.4B. For detailed data — including Novo Nordisk A/S revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Novo Nordisk A/S (NOVO-B.CO) stock price is $266.55. The stock is traded on CPH under the ticker symbol NOVO-B.CO. The 52-week range is $224.25 – $533.40.